Drug Trial Radar · NCT03495102
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Jun 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,842
Actual
Start
Apr 5, 2018
Primary completion
May 28, 2019
Study completion Oct 10, 2019
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of investigational doses of once weekly dulaglutide when added to metformin in participants with type 2 diabetes with inadequate blood sugar control.
Conditions
- Diabetes Mellitus, Type 2
Interventions
DulaglutideDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Hemoglobin A1c (HbA1c) From BaselineTime frame: Baseline, Week 36
Locations
208 sites in 16 countries. Site status is shown where the registry gives one.
Synexus- Chandler
Chandler, Arizona
Synexus/Central Arizona Medical Associates, PC
Mesa, Arizona
Central Phoenix Med Clinic LLC
Phoenix, Arizona
Arkansas Clinical Research
Little Rock, Arkansas
Anaheim Clinical Trials, LLC
Anaheim, California
Valley Research
Fresno, California
National Research Institute
Huntington Park, California
National Research Institute
Los Angeles, California
Catalina Research Institute, LLC
Montclair, California
Valley Clinical Trials, Inc.
Northridge, California
Pacific Research Partners, LLC
Oakland, California
National Research Institute
Panorama City, California
Sierra Clinical Research
Roseville, California
Artemis Institute for Clinical Research
San Diego, California
Care Access Research
Santa Clarita, California
Encompass Clinical Research
Spring Valley, California
University Clinical Investigators, Inc.
Tustin, California
Diablo Clinical Research
Walnut Creek, California
Chase Medical Research, LLC
Waterbury, Connecticut
ALL Medical Research, LLC
Cooper City, Florida
Clinical Research of South Florida
Coral Gables, Florida
Suncoast Research Group, LLC
Miami, Florida
New Horizon Research Center
Miami, Florida
Oviedo Medical Research
Oviedo, Florida
Urban Family Practice Associates, PC
Marietta, Georgia
In-Quest Medical Research, LLC- Peachtree Corners
Peachtree Corners, Georgia
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii
East West Medical Institute
Honolulu, Hawaii
Elite Clinical Trials LLLP
Blackfoot, Idaho
Saltzer Medical Group. P.A.
Nampa, Idaho
Prairie Education and Research Cooperative
Springfield, Illinois
Synexus/Clinical Research Advantage
Evansville, Indiana
Midwest Institute for Clinical Research
Indianapolis, Indiana
Iderc, P.L.C.
West Des Moines, Iowa
InterMed, PA
Portland, Maine
MedStar Health Research Institute
Hyattsville, Maryland
NECCR PrimaCare Research, LLC
Fall River, Massachusetts
Aa Mrc Llc
Flint, Michigan
Troy Internal Medicine, PC
Troy, Michigan
Clinical Research Professionals
Chesterfield, Missouri
Showing 40 of 208 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.